placeholder
Alibaba Group, the Chinese e-commerce giant behind Alibaba.com and AliExpress, has agreed to pay $600 million to settle Justice Department allegations that its marketplaces let merchants ship illegal pharmaceuticals, controlled substances and pill presses into the United States. The settlement, announced Wednesday, also covers Alibaba's former U.S. payment processor, AUS Merchant Services.
At a Glance
- Alibaba and AUS Merchant Services agreed to non prosecution deals worth $600 million combined
- Alibaba admitted to roughly 80,000 prohibited transactions from January 2016 through December 2024
- Those transactions carried a gross merchandise value exceeding $200 million
- Undercover agents made more than 40 purchases of banned pharmaceuticals and equipment on the platforms
- Alibaba shares traded near recent levels as investors weighed the settlement against the company's broader business
What the Settlement Covers
Federal prosecutors accused both companies of violating the Federal Food, Drug, and Cosmetic Act by allowing sellers to move restricted goods, including regulated chemicals and pill counterfeiting machinery, through Alibaba.com and AliExpress.com. Investigators say internal employees at Alibaba had raised concerns about whether the platform's screening tools were adequate, even though rules barring such sales already existed on paper. The company also ran a private messaging tool that some sellers reportedly used to coordinate illicit deals, with some pointing buyers toward encrypted apps to finish transactions outside the platform's view.
AUS Merchant Services, once known as Alipay U.S. and a subsidiary of Ant Group, acknowledged that holes in its anti money laundering controls let certain merchants push prohibited payments through its system. Wire transfer data was not always fed into its monitoring software, according to the Justice Department, which meant suspicious transfers from high risk regions could slip through undetected. In one case cited by prosecutors, a seller kept shipping banned products to American buyers even after AUS had already flagged and reported that account.
Under the agreement, Alibaba will pay $125 million in criminal fines plus a $200 million forfeiture. AUS Merchant Services will pay $85 million in fines and forfeit $190 million. Both companies agreed to rebuild their compliance programs and stay in ongoing contact with federal prosecutors as part of the resolution.
What the Numbers Say
Alibaba's stock trades at a price to earnings ratio that remains well below many U.S. tech peers, reflecting years of regulatory pressure from Beijing and now this fresh legal bill from Washington. The company's market capitalization sits in the hundreds of billions, and a $600 million penalty, while large in absolute terms, is a modest fraction of that total. Earnings per share have shown steady if uneven growth as Alibaba works through restructuring efforts across its cloud, logistics and retail units.
Momentum readings on the stock, measured through relative strength index levels, have hovered in a neutral to slightly overbought zone in recent sessions, suggesting the settlement news has not triggered a sharp technical breakdown. Shares remain within their 52 week trading range, closer to the upper half than the lows seen earlier in the year. Alibaba also pays a dividend, giving income focused holders a yield that adds a layer of return beyond price appreciation.
The bull case rests on Alibaba's scale, its cloud computing growth and a valuation that some see as cheap relative to sales and cash flow. Bears point to recurring regulatory entanglements, now spanning both Chinese and American authorities, along with margin pressure from heavy competition in domestic e-commerce.
p][image: warehouse shipping boxes]]Why Regulators Pursued the Case
Assistant Attorney General Brett A. Shumate framed the settlement as a warning to marketplace operators everywhere.
